文献速递乳腺乳腺X线USMR

个性化筛查:这是前进的方向吗?

Personalised screening: is this the way forward?
PubMed 文献 · Clin Radiol · 2017-12-19

乳腺X线筛查已在多国实施,多数对50-69岁女性每2年检查一次。结合乳腺密度和单核苷酸多态性的模型可预测乳腺癌高风险女性;数字乳腺断层合成、自动乳腺超声、对比增强乳腺摄影和简化乳腺MRI均可提高癌症检出,尤其对致密乳腺且风险增高者。本文综述文献以明确这些技术的现状;其成本效益需进一步研究,筛查试验应报告所发现额外肿瘤的性质。

要点

  • 数字乳腺断层合成使癌症检出率提高约15%,并相应降低召回率。
  • 自动乳腺超声根据受检队列不同每1000例增加2-4例癌症检出,但召回率增加,后续筛查轮次中趋于下降。
  • 对比增强乳腺摄影敏感度极高几乎与MRI相当,特异度略优;简化乳腺MRI与标准方案MRI检查几乎等效。

核心结论

  • 数字乳腺断层合成、自动乳腺超声、对比增强乳腺摄影和简化乳腺MRI均可提高癌症检出,尤其对致密乳腺且风险增高的女性;这些技术的成本效益需进一步研究,筛查试验应报告所发现额外肿瘤的性质。

研究设计与样本

  • 本文为文献综述,检索范围与纳入文献数量原文未报告。

关键影像表现/征象

  • 数字乳腺断层合成使癌症检出率提高约15%,并相应降低召回率。
  • 自动乳腺超声根据受检队列不同每1000例增加2-4例癌症检出,并导致召回率增加,召回率在后续筛查轮次中趋于下降。
  • 对比增强乳腺摄影敏感度极高几乎与MRI相当,特异度略优。
  • 简化乳腺MRI与标准方案MRI检查几乎等效,使其可能被视为高风险女性的筛查工具。

诊断标准与关键数值

  • 乳腺X线摄影对最致密类别乳腺组织女性的敏感度差,即使乳腺组织呈不均匀致密的女性也可能从额外补充影像中获益。

临床应用与阅片要点

  • 本文综述文献以明确数字乳腺断层合成、自动乳腺超声、对比增强乳腺摄影和简化乳腺MRI这些技术的现状。

局限性

  • 这些技术的成本效益需进一步研究。
  • 筛查试验应报告所发现额外肿瘤的性质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Screening with mammography has been implemented in many countries across the world with most offering 2-yearly examinations between the ages of 50-69 years. Robust modelling tools that include breast density and single nucleotide polymorphisms (SNPs) have been developed to predict which women are most likely to develop breast cancer. Mammographic sensitivity is poor in women with the densest category of breast tissue, and even women with heterogeneously dense tissue may benefit from additional supplemental imaging. Digital breast tomosynthesis (DBT), automated breast ultrasound (ABUS), contrast-enhanced mammography (CESM) or abbreviated (ABB) magnetic resonance imaging (MRI) all offer the opportunity to increase cancer detection, especially in women with dense breasts at increased risk of cancer. DBT increases cancer detection by around 15% with a corresponding reduction in recall rates; ABUS has been shown to increase cancer detection by between 2-4/1,000 depending on the cohort being examined and results in increased recalls, which tend to fall in subsequent screening rounds; CESM has very high sensitivity almost matching MRI with slightly improved specificity; ABB-MRI has been shown to be virtually equivalent to standard protocol MRI examinations, making this a technique that could be considered as a screening tool in high-risk women. This article reviews the literature to establish the current status of these techniques. The cost-effectiveness of these techniques requires further investigation and screening trials should report the nature of any additional tumours that are found.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Gilbert FJ, Kaya A. Personalised screening: is this the way forward? Clin Radiol. 2017. PMID: 29273223. doi:10.1016/j.crad.2017.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。